公司资料
Processa Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- PCSA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
2.13 USD (-12.35%)
收盘价
最后更新: 2026年8月17日
8.03M USD
市值
股价为何变动
As of Aug 17, 2026, PCSA closed down 12.3% at $2.13. No new same-company headline was identified in the current news window.
公司概览
业务概览
Processa Pharmaceuticals is a development-stage company focused on improving the safety and efficacy of existing oncology drugs through next-generation formulations and combinations. Its story centers on making known medicines more usable in difficult cancer settings.
所在地与行业分类
Processa is headquartered in the United States and listed on NASDAQ. It sits in small-cap biopharmaceutical development.
商业模式特征
The business depends on clinical progress, formulation strategy, and the ability to advance a narrow pipeline with limited resources. Investors typically watch proof-of-concept data and partnership or financing activity.
生物医药行业定位
Processa occupies a niche oncology-development position within biotech. It is a small-cap story where the commercial value depends on whether modified therapies can truly improve outcomes.
未来催化剂
- Processa’s catalysts are its rare-disease and oncology programs, especially any development update that clarifies which assets still matter. The company needs a cleaner clinical path.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。